AI model to predict breast cancer treatment response
Part of Cancer, Skin clinical trials.
This trial uses an artificial intelligence model to predict how well breast cancer responds to neoadjuvant therapy (treatment before surgery). It aims to improve treatment planning by analyzing MRI scans taken before and after therapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Women aged 18 or older with invasive breast cancer
- Stage I to III breast cancer
- Had an MRI before and after neoadjuvant therapy
- Planning to have surgery (mastectomy or breast-conserving) after neoadjuvant therapy
- Treated at a participating research center between January 2024 and October 2025
- Good performance status (ECOG score 0, 1, or 2)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether an AI tool can predict how well breast cancer responds to chemotherapy given before surgery. Your tumor sample from a needle biopsy will be analyzed to see if the AI's prediction matches your actual treatment outcome.
This trial tests an artificial intelligence (AI) model that looks at pictures of breast tissue to find cancer. It may help improve early detection and reduce the need for invasive tests.
This trial uses artificial intelligence to analyze images of your tumor tissue to predict if breast cancer might spread to other parts of the body. It may help doctors better understand your individual risk and guide treatment decisions.
This trial tests a non-invasive, AI-based monitoring program for people with solid tumors. It aims to help track how you’re doing during or after curative-intent treatment, using information collected without extra procedures.
This study tests a new artificial intelligence software called Kenko Breast AI+ that analyzes breast MRI scans to help doctors better detect and monitor breast cancer. If you've had or are planning to have a breast MRI for cancer concerns, this trial might be right for you.
This study uses artificial intelligence to look at your tumor samples and predict how well pyrotinib (a targeted pill) will work for your advanced breast cancer. It may help guide future treatment decisions by finding patterns that predict response.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.